Phase
Condition
Spinal Cord Injuries
Treatment
Biostim-5 transcutaneous spinal stimulator
Clinical Study ID
Ages 4-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
history of chronic, acquired SCI, (>1 year since injury);
SCI involves cervical and/or high thoracic (T1) levels
moderate to severe upper extremity deficit as assessed by the PediatricNeuromuscular Recovery Upper Extremity Scale (scores less than 4A out of a 12 pointrange from 1A-4C on upper extremity tasks, e.g. including inability to fully reachoverhead, grasp, or pinch without compensation)
discharged from in-patient rehabilitation
Exclusion
Exclusion Criteria:
botox use within past 3 months;
current baclofen use
unhealed upper extremity fracture
any other medical complication limiting participation in the assessments and/oractivity- based upper extremity training;
congenital SCI
total ventilator dependence
Study Design
Study Description
Connect with a study center
Department of Neurosurgery
Louisville, Kentucky 40202
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.